Win the market your innovation deserves.
Commercial strategy, market access, and go-to-market services for biomedical innovators.
We help you turn Just Might into Just Mighty.
The best products don’t always win. The best-positioned ones do. We help you build the commercial strategy, market access, and go-to-market plans that lead to successful fundraising, a clear path to reimbursement, accelerated device adoption, and faster time to revenue.
Commercial Phases
Our launch services integrate with every phase of your commercialization journey, from Foundation through Growth. Whether you’re bringing your first product to market or expanding an established portfolio, we calibrate our work to your phase and goals.
Disciplines
Our disciplines bring together commercial strategy, market access, evidence and insights, and go-to-market, aligned to build the path from innovation to adoption.
Practice Areas
We work across medical device, diagnostics, drug delivery, biotechnology, health technology, health and wellness, and veterinary markets. Each engagement is shaped by your market, competitive landscape, and growth objectives.
Case Studies
Trusted commercial strategy partners
We help biomedical companies build the commercial strategy, market access, and go-to-market plans that win markets, drawing on our experience across the biomedical sector.
Great Innovations Need Great Strategies to Succeed
Investors, clinicians, payers, and health systems each need a different reason to commit. In a free consultation, we’ll identify the gaps in your commercial strategy and how to close them, at no cost or obligation.
What’s the ROI on Better Strategy?
Stronger commercial strategy leads to successful fundraising, a clear path to reimbursement, accelerated device adoption, and faster time to revenue.
Corporate Strategy
Aim Medical Robotics
Aim Medical Robotics enters its Series B raise with a brand built to compete at the highest level—strategically grounded, visually distinctive, and deployed consistently across every investor, clinical, and commercial touchpoint.
Investor Readiness
Vervia™
Built a strategic product brand, including identity, messaging, and investor materials, that positioned the remote diagnostics platform for stakeholder engagement and Series B fundraising.
Accelerated to Market
Olari
Deployed an intelligent brand strategy to quickly gain momentum in the competitive practice management/EMR category and position the company for adoption and growth.
CRYSTAL IS
Improved Adoption
Successfully deployed a strategic brand and a comprehensive toolbox of brand assets which led the brand to the top of the device category.
Learn More
STERLING
Improved Valuation
Successfully overhauled the brand strategy, brand design, and brand engagement efforts, achieving the strategic acquisition of the brand.
Learn More
The Belief Gap: Why Brilliant MedTech Innovation Fails to Win Stakeholders
Brilliant innovators with breakthrough technology can’t get traction. Not because the science is weak. Not because there’s no market. Not because the team can’t execute. How to close the distance between what founders know and what investors, clinicians and buyers believe.